People: ACADIA Pharmaceuticals Inc (ACAD.O)
17 May 2013
Ms. Laura A. Brege is Independent Director of ACADIA Pharmaceuticals, Inc., since May 1, 2008. Ms. Brege is Executive Vice President and Chief Operating Officer of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, where she is responsible for sales and marketing, medical affairs, legal, and compliance functions. She joined Onyx in June 2006 as Executive Vice President and Chief Business Officer and was promoted to her current position in October 2007. Before joining Onyx, Ms. Brege was a general partner at Red Rock Capital Management, a venture capital firm specializing in early stage financing for technology companies, since 1999. Prior to Red Rock, she was the Senior Vice President and Chief Financial Officer at COR Therapeutics. Earlier in her career, Ms. Brege served as Vice President and Chief Financial Officer at Flextronics and Vice President and Treasurer of The Cooper Companies. The Nominating and Corporate Governance Committee believes that Ms. Brege’s industry background, including her experience as an officer of public companies in the biotechnology industry, position her to make an effective contribution to the Board and the Audit Committee. In addition, her past financial experience and current knowledge of financing trends are extremely to the Board when considering financing strategies for the Company. Ms. Brege earned her undergraduate degree from Ohio University and has an M.B.A. from the University of Chicago. Ms. Brege also serves on the boards of Angiotech Pharmaceuticals, Inc. and The Ohio University Foundation.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|